Atlas Trials

Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases

Clinical trial NCT00121420 · TERMINATED

Trial details

NCT number
NCT00121420
Sponsor
Pharmacyclics LLC.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Neoplasm MetastasisBrain Neoplasms
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.